Willingness to pay for a quality-adjusted life year: Implications for societal health care resource allocation

被引:163
|
作者
King, JT
Tsevat, J
Lave, JR
Roberts, MS
机构
[1] VA Connecticut Healthcare Syst, Neurosurg Sect, West Haven, CT 06516 USA
[2] Yale Univ, Dept Neurosurg, New Haven, CT USA
[3] Univ Cincinnati, Dept Internal Med, Inst Hlth Policy & Hlth Serv Res, Med Ctr, Cincinnati, OH USA
[4] Univ Cincinnati, Ctr Clin Effectiveness, Inst Hlth Policy & Hlth Serv Res, Med Ctr, Cincinnati, OH USA
[5] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA
[6] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA
[7] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA USA
[8] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[9] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA
关键词
cost-effectiveness analysis; preferences; QALYs; utility; willingness to pay;
D O I
10.1177/0272989X05282640
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. Methods. The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog scale, and WTP then they calculated WTP/QALY ratios. The ratios were compared with several proposed cost/QALY cost-effectiveness ratio thresholds, the value-of-life literature, and with WTP/QALY ratios derived from published preference research. Results. Mean WTP/QALY ratios ranged from $12,500 to $32,200 (2003 $US). All values were below most published cost-effectiveness ratio thresholds, below the ratio from a prototypic medical treatment covered by Medicare (i.e., renal dialysis), and below ratios from the value-of-life literature, The WTP/QALY ratios were similar to those calculated from published preference data for patients with symptomatic menopause, dentofacial deformities, asthma, or dermatologic disorders. Conclusions. WTP/QALY ratios calculated using preference data collected from diverse populations are lower than most proposed thresholds for determining what is "cost-effective," Current proposed cost-effectiveness ratio thresholds may overestimate the willingness of society to pay for medical interventions.
引用
收藏
页码:667 / 677
页数:11
相关论文
共 50 条
  • [31] Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran
    Lankarani, Kamran Bagheri
    Ghahramani, Sulmaz
    Moradi, Najmeh
    Shahraki, Hadi Raeisi
    Lotfi, Farhad
    Honarvar, Behnam
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (06) : 837 - 846
  • [32] Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
    Bazarbashi, Shouki
    De Vol, Edward B.
    Maraiki, Fatma
    Al-Jedai, Ahmed
    Ali, Afshan A.
    Alhammad, Ali M.
    Aljuffali, Ibrahim A.
    Iskedjian, Michael
    PHARMACOECONOMICS-OPEN, 2020, 4 (04) : 625 - 633
  • [33] Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran
    Kamran Bagheri Lankarani
    Sulmaz Ghahramani
    Najmeh Moradi
    Hadi Raeisi Shahraki
    Farhad Lotfi
    Behnam Honarvar
    Applied Health Economics and Health Policy, 2018, 16 : 837 - 846
  • [34] A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
    Nimdet, Khachapon
    Chaiyakunapruk, Nathorn
    Vichansavakul, Kittaya
    Ngorsuraches, Surachat
    PLOS ONE, 2015, 10 (04):
  • [35] Willingness-to-Pay for a Quality-Adjusted Life-Year Due to Pain Associated with Herpes Zoster: Patient and Community Perspectives
    Ortega-Sanchez, Ismael R.
    Lieu, Tracy A.
    Ray, Tomas
    Kleiman, Ken
    Rusinak, Donna
    Posser, Lisa A.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 33 - 33
  • [36] A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population
    Ye, Ziping
    Ma, Jia
    Liu, Fuyao
    Wang, Chen
    Zhou, Ziyang
    Sun, Lihua
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 53 - 61
  • [37] Evaluation of willingness to pay per quality-adjusted life year for a cure A contingent valuation method using a scenario-based survey
    Song, Hyun Jin
    Lee, Eui-Kyung
    MEDICINE, 2018, 97 (38)
  • [38] Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues
    Devlin, Nancy J.
    Drummond, Michael F.
    Mullins, C. Daniel
    VALUE IN HEALTH, 2024, 27 (06) : 689 - 691
  • [39] Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study
    Chugh, Yashika
    Jyani, Gaurav
    Trivedi, Mayur
    Albert, Sandra
    Kar, Sitanshu Sekhar
    Patro, Binod
    Raman, Swati
    Rajsekar, Kavitha
    Baker, Rachel Mairi
    Donaldson, Cam
    Prinja, Shankar
    BMJ OPEN, 2023, 13 (02):